3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
2
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
NET
1
Endocrine
1
CNS
1
Conditions
Breast Neoplasms
233
Neoplasms
163
Prostatic Neoplasms
143
Colorectal Neoplasms
105
Lung Neoplasms
97
Leukemia, Myeloid, Acute
74
Pancreatic Neoplasms
72
Carcinoma, Non-Small-Cell Lung
71
Multiple Myeloma
61
Brain Neoplasms
58
Precursor Cell Lymphoblastic Leukemia-Lymphoma
51
Melanoma
51
Glioblastoma
48
Carcinoma, Hepatocellular
45
Ovarian Neoplasms
44
Head and Neck Neoplasms
43
Uterine Cervical Neoplasms
41
Neoplasm Metastasis
41
Sarcoma
40
Glioma
39
Stomach Neoplasms
37
Hematologic Neoplasms
37
Squamous Cell Carcinoma of Head and Neck
35
Recurrence
35
Lymphoma, Non-Hodgkin
34
Carcinoma, Renal Cell
34
Esophageal Neoplasms
33
Lymphoma
32
Leukemia
32
Rectal Neoplasms
31
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Sarcoma, Synovial
×
30 days
×
Clear all
NCT06607692
2026-06-04
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled